that will support continuous growth momentum in demand for medical devices in Thailand. In 2019, the Company has improved and increased the sales team to increase sales efficiency in distributor of
share. 8. Sources of Financing The Company will finance this Transaction with the capital received from the capital increase of the Company of Baht 9.90 million. As of 31 December 2019, the Company has
finance this Transaction with the capital received from the capital increase of the Company of Baht 9.90 million. As of 31 December 2019, the Company has cash and cash equivalent as well as current
be expected to increase a lot in the future Since it is an area in the Eastern Economic Corridor area. There is a high rate of growth in the industrial sector. The management sees the opportunity to
, an increase of 121 million baht or 9% y-y. The Company reported net profit attributed to owners of the parent of 1,184 million baht, an increase of 128 million baht or 12% y-y and 17% q-q, and earning
; (6) asset value of mutual fund; (7) issuance of investment units and an increase or reduction of registered capital whereby there shall be a requirement specifying that the management company shall
ENDED DECEMBER 31, 2017 1. Operating performance as compar ison analysis between those in the year 2017 and 2016 in consolidated financial statement. Description 2017 2016 Increase (Decrease) Amount
subsidiaries financial statement for the fiscal year 2014, ended as of December 31, 2014 (Revised Version) which details are as following; Result 2014 (Revised Version) 2013 Increase (Decrease) Million Baht
subsidiaries financial statement for the fiscal year 2015, ended as of December 31, 2015 which details are as following; Results 2015 (Revised Version) 2014 (Revised Version) Increase (Decrease) Million Baht